Bay Shore Trust - 15 Nov 2023 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role: 10%+ Owner
Signature: /s/ Michelle Yanez, Attorney-in-Fact for Brian McNulty, Trustee
Issuer symbol: MIRA
Transactions as of: 15 Nov 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Nov 2023, 17:09:32 UTC
Next filing: 08 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRA	Common Stock Warrant (right to buy)	Award		+700,000			700,000	15 Nov 2023	Common Stock	700,000	$2.00	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.

Content

The warrants were issued to MIRALOGX LLC ("MIRALOGX"), a wholly-owned subsidiary of the Bay Shore Trust (the "Trust"), a greater than 10% owner of the Issuer, in connection with an Exclusive License Agreement, dated November 15, 2023, by and between MIRALOGX and the Issuer. The Trust may be deemed to beneficially own the shares held by MIRALOGX but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.